Climb Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Climb Bio (Nasdaq: CLYM) has announced its participation in the upcoming Oppenheimer 35th Annual Healthcare Life Sciences Conference, scheduled for February 11-12, 2025. The company's executive team will deliver a presentation on February 12, 2025, at 9:20 a.m. ET.
The virtual conference will feature both a formal presentation and one-on-one investor meetings. The event provides an opportunity for investors and stakeholders to gain insights into Climb Bio's developments and strategic initiatives.
Climb Bio (Nasdaq: CLYM) ha annunciato la sua partecipazione alla prossima 35ª Conferenza Annuale sulle Scienze della Vita Oppenheimer, in programma per l'11-12 febbraio 2025. Il team esecutivo dell'azienda sarà presente con una presentazione il 12 febbraio 2025, alle 9:20 a.m. ET.
La conferenza virtuale includerà sia una presentazione formale che incontri individuali con gli investitori. L'evento offre un'opportunità per gli investitori e le parti interessate di ottenere informazioni sui sviluppi e le iniziative strategiche di Climb Bio.
Climb Bio (Nasdaq: CLYM) ha anunciado su participación en la próxima 35ª Conferencia Anual de Ciencias de la Salud de Oppenheimer, programada para el 11 y 12 de febrero de 2025. El equipo ejecutivo de la compañía realizará una presentación el 12 de febrero de 2025, a las 9:20 a.m. ET.
La conferencia virtual contará con una presentación formal y reuniones individuales con inversores. El evento brinda una oportunidad para que inversores y partes interesadas obtengan información sobre los desarrollos e iniciativas estratégicas de Climb Bio.
Climb Bio (Nasdaq: CLYM)는 다가오는 오펜하이머 제35회 연례 헬스케어 생명과학 콘퍼런스에 참석할 것이라고 발표했습니다. 이 행사는 2025년 2월 11일부터 12일까지 예정되어 있으며, 회사의 경영진 팀은 2025년 2월 12일 오전 9:20 동부 시간(ET)에 발표를 진행할 것입니다.
이번 가상 콘퍼런스에서는 공식 발표와 투자자와의 일대일 미팅이 진행됩니다. 이 행사는 투자자 및 이해관계자들에게 Climb Bio의 발전과 전략적 이니셔티브에 대한 통찰력을 획득할 수 있는 기회를 제공합니다.
Climb Bio (Nasdaq: CLYM) a annoncé sa participation à la prochaine 35e Conférence Annuelle Oppenheimer sur les Sciences de la Vie et la Santé, prévue pour le 11 et 12 février 2025. L'équipe dirigeante de l'entreprise présentera une intervention le 12 février 2025 à 9h20 ET.
La conférence virtuelle comprendra à la fois une présentation formelle et des réunions individuelles avec des investisseurs. Cet événement offre aux investisseurs et aux parties prenantes une occasion d'obtenir des informations sur les développements et les initiatives stratégiques de Climb Bio.
Climb Bio (Nasdaq: CLYM) hat seine Teilnahme an der bevorstehenden 35. jährlichen Gesundheits- und Lebenswissenschaftskonferenz von Oppenheimer bekannt gegeben, die für den 11. und 12. Februar 2025 geplant ist. Das Führungsteam des Unternehmens wird am 12. Februar 2025 um 9:20 Uhr ET eine Präsentation halten.
Die virtuelle Konferenz wird sowohl eine formale Präsentation als auch Einzelgespräche mit Investoren umfassen. Die Veranstaltung bietet Investoren und Interessengruppen die Möglichkeit, Einblicke in die Entwicklungen und strategischen Initiativen von Climb Bio zu gewinnen.
- None.
- None.
WELLESLEY, Mass., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) today announced that members of its executive team will participate at the Oppenheimer 35th Annual Healthcare Life Sciences Conference being held virtually February 11-12, 2025.
Oppenheimer 35th Annual Healthcare Life Sciences Conference
Format: Presentation and one-on-one investor meetings
Date: February 12, 2025
Time: 9:20 a.m. ET
Webcast: Click here
About Climb Bio, Inc.
Climb Bio, Inc. is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Company’s pipeline includes, budoprutug, an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has potential to treat a broad range of B-cell mediated diseases, and CLYM116, an anti-APRIL monoclonal antibody currently in IND-enabling studies for IgA nephropathy. For more information, please visit climbbio.com.
Investors
Chris Brinzey
ICR Healthcare
chris.brinzey@icrhealthcare.com
339-970-2843
Media
Jon Yu
ICR Healthcare
jon.yu@icrhealthcare.com
475-395-5375
FAQ
When is Climb Bio (CLYM) presenting at the Oppenheimer Healthcare Conference 2025?
What type of meetings will CLYM hold at the Oppenheimer Conference 2025?
Is the Oppenheimer Healthcare Conference 2025 where CLYM is presenting in-person or virtual?
What dates is the Oppenheimer Healthcare Conference 2025 running?
